Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.
Brett Favre told TMZ Sports that he was diagnosed with Parkinson’s disease in January after he began having trouble using his right arm and was unable to hold a screwdriver steady ...
Some results have been hidden because they may be inaccessible to you